Results 21 to 30 of about 53,272 (209)

Immunotherapy and Vaccine Development in Viral Hepatitis

, 2013
Tajiri, Kazuto, Shimizu, Yukihiro
openaire   +4 more sources

Community screening for hepatitis C virus infection in a low-prevalence population

BMC Public Health, 2019
Background Age cohort screening for hepatitis C virus (HCV) might be an effective strategy if the majority of undiagnosed cases are concentrated in a particular age group.
Karen K. Kyuregyan, Elena Yu. Malinnikova, Natalia V. Soboleva, Olga V. Isaeva, Anastasia A. Karlsen, Vera S. Kichatova, Ilya A. Potemkin, Elena V. Schibrik, Olga A. Gadjieva, Boris A. Bashiryan, Natalya N. Lebedeva, Igor L. Serkov, Anna Yankina, Claudio Galli, Mikhail I. Mikhailov   +14 more
doaj   +1 more source

The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis

Frontiers in Immunology, 2021
About 250 million people worldwide are chronically infected with Hepatitis B virus (HBV), contributing to a large burden on public health. Despite the existence of vaccines and antiviral drugs to prevent infection and suppress viral replication ...
Fenglin Zhao, Fenglin Zhao, Xiaoyu Xie, Xiaoyu Xie, Xiaoyu Xie, Xu Tan, Xu Tan, Hongli Yu, Hongli Yu, Miaomiao Tian, Miaomiao Tian, Huanran Lv, Huanran Lv, Chengyong Qin, Chengyong Qin, Chengyong Qin, Jianni Qi, Jianni Qi, Jianni Qi, Qiang Zhu, Qiang Zhu, Qiang Zhu, Qiang Zhu   +22 more
doaj   +1 more source

Vaccines for neonatal viral infections: Hepatitis B vaccine

Expert Review of Vaccines, 2004
In many parts of the world, intervention in the neonatal period is required for prevention of hepatitis B virus infection and its consequences.
F T, Cutts, A J, Hall
openaire   +2 more sources

Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?

Vaccines, 2021
Molecular pharming or the technology of application of plants and plant cell culture to manufacture high-value recombinant proteins has progressed a long way over the last three decades.
Srividhya Venkataraman, Kathleen Hefferon, Abdullah Makhzoum, Mounir Abouhaidar   +3 more
doaj   +1 more source

Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study

BMC Infectious Diseases, 2021
Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs.
Semvua B. Kilonzo, Daniel W. Gunda, David C. Majinge, Hyasinta Jaka, Paulina M. Manyiri, Fredrick Kalokola, Grahame Mtui, Elichilia R. Shao, Fatma A. Bakshi, Alex Stephano   +9 more
doaj   +1 more source

Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination

Биопрепараты: Профилактика, диагностика, лечение, 2018
The article presents the results of a retrospective analysis of viral hepatitis B incidence in the Russian Federation from 2013 to 2017, taking into account the use of vaccines included into the National Immunisation Schedule and the Immunisation ...
L. M. Khantimirova, T. Yu. Kozlova, E. L. Postnova, V. A. Shevtsov, A. V. Rukavishnikov   +4 more
doaj   +1 more source

Prevention of Viral Hepatitis and Vaccination

Korean Journal of Medicine, 2012
Hepatitis viruses are most important cause of acute and chronic hepatitis. In past, hepatitis B virus was one of the major causes of acute hepatitis. Recently, around 60-70% of acute hepatitis is attributed to hepatitis A virus infection. In this article, we will discuss the route of hepatitis virus infection, how to prevent transmission of viral ...
Yoo-Kyung Cho, Byung-Cheol Song
openaire   +1 more source

Antiviral activity of zinc against hepatitis viruses: current status and future prospects

Frontiers in Microbiology, 2023
Viral hepatitis is a major public health concern globally. World health organization aims at eliminating viral hepatitis as a public health threat by 2030.
Shiv Kumar, Shabnam Ansari, Sriram Narayanan, C. T. Ranjith-Kumar, Milan Surjit   +4 more
doaj   +1 more source

The Immunological and Epidemiological Effectiveness of Pediatric Single-Dose Vaccination against Hepatitis A 9 to 11 Years after Its Implementation in the Tyva Republic, the Russian Federation

Vaccines
Since 2012, universal single-dose HAV vaccination in children aged 3 years and older has been implemented in the Tyva Republic, a region of the Russian Federation.
Maria A. Lopatukhina, Karen K. Kyuregyan, Anastasia A. Karlsen, Fedor A. Asadi Mobarkhan, Ilya A. Potemkin, Vera S. Kichatova, Olga V. Isaeva, Lyudmila Yu. Ilchenko, Anna A. Saryglar, Mikhail I. Mikhailov   +9 more
doaj   +1 more source